Biodesix Debt/Equity Ratio 2020-2024 | BDSX

Biodesix debt/equity ratio from 2020 to 2024. Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.

Biodesix Debt/Equity Ratio 2020-2024 | BDSX

Biodesix debt/equity ratio from 2020 to 2024. Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.
Related Stocks
Company NameMarket
Cap
Elevance Health (ELV)$96.9B
Cencora (COR)$46.1B
DiDi Global (DIDIY)$23.2B
ICON (ICLR)$18.7B
Revvity (RVTY)$15.5B
Avantor (AVTR)$15.5B
Natera (NTRA)$15.4B
Viatris (VTRS)$13.9B
BioMerieux (BMXMF)$13.6B
Solventum (SOLV)$12.6B
CochLear (CHEOY)$12.6B
Medpace Holdings (MEDP)$10.2B
Charles River Laboratories (CRL)$9.7B
Sonic Healthcare (SKHHY)$8.3B
HealthEquity (HQY)$7.8B
Doximity (DOCS)$7.8B
Bausch + Lomb (BLCO)$7B
Life Times (LTH)$4.8B
PACS (PACS)$4.5B
Sotera Health (SHC)$4.4B
Organon (OGN)$4.2B
Surgery Partners (SGRY)$3.8B
BrightSpring Health Services (BTSG)$3.1B
Ardent Health Partners (ARDT)$2.6B
Alignment Healthcare (ALHC)$2.5B
Concentras Parent (CON)$2.5B
Premier (PINC)$2.3B
GoodRx Holdings (GDRX)$2.3B
GeneDx Holdings (WGS)$2.1B
Ryman Healthcare (RYHTY)$2B